Latest Intelligence on Pharmaceuticals and Healthcare in Thailand

Published within

« | 1 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Boehringer Ingelheim: free antivirals for developing countries

Published By Datamonitor
05 Dec 2000
CommentWire
CommentWire

Trinity: hoping to boost investor confidence with NDA

Published By Datamonitor
31 Jul 2001
CommentWire
CommentWire

GlaxoSmithKline: cutting the cost of HIV drugs

GlaxoSmithKline's fifth round of price cuts since 1997 includes 14 HIV drugs reduced by an average of 21%. The biggest reduction is a 40% cut in the price of Ziagen, a first and second line AIDS treatment. With the use of compulsory licenses becoming more frequent among developing countries, GSK will hope that such price cuts appease governments and prevent their patents being bypassed.

Published By Datamonitor
21 Feb 2008

« | 1 | » »|

No help is available.